New trial
Becotatug Vedotin Plus Anti-PD-1 and S-1 in Patients With EGFR-Positive Advanced Pancreatic Cancer Who Have Failed at Least One Line of Standard Therapy
Why it was picked newest record on or before this date
New trials, papers and changes to existing records, compiled daily from the public registries
New trial
Why it was picked newest record on or before this date
New trial
Why it was picked newest record on or before this date
New paper
Why it was picked newest record on or before this date
New paper
Why it was picked newest record on or before this date
New paper
Why it was picked newest record on or before this date
New paper
New paper
New paper
New paper
Compiled by the knowledge layer from its change log. Every headline opens the underlying record; every identifier links to its source.